The candidate tumor suppressor gene, RASSF1A , from human chromosome 3p21.3 is involved in kidney tumorigenesis
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Clear cell-type renal cell carcinomas (clear RCC) are characterized almost universally by loss of heterozygosity on chromosome 3p, which usually involves any combination of three regions: 3p25-p26 (harboring the VHL gene), 3p12-p14.2 (containing the FHIT gene), and 3p21-p22, implying inactivation of the resident tumor-suppressor genes (TSGs). For the 3p21-p22 region, the affected TSGs remain, at present, unknown. Recently, the RAS association family 1 gene (isoform RASSF1A), located at 3p21.3, has been identified as a candidate lung and breast TSG. In this report, we demonstrate aberrant silencing by hypermethylation of RASSF1A in both VHL -caused clear RCC tumors and clear RCC without VHL inactivation. We found hypermethylation of RASSF1A's GC-rich putative promoter region in most of analyzed samples, including 39 of 43 primary tumors (91%). The promoter was methylated partially or completely in all 18 RCC cell lines analyzed. Methylation of the GC-rich putative RASSF1A promoter region and loss of transcription of the corresponding mRNA were related causally. RASSF1A expression was reactivated after treatment with 5-aza-2′-deoxycytidine. Forced expression of RASSF1A transcripts in KRC/Y, a renal carcinoma cell line containing a normal and expressed VHL gene, suppressed growth on plastic dishes and anchorage-independent colony formation in soft agar. Mutant RASSF1A had reduced growth suppression activity significantly. These data suggest that RASSF1A is the candidate renal TSG gene for the 3p21.3 region.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene
Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F.-M., Orcutt, M. L., Stackhouse, T., Kuzmin, I., Modi, W., Geil, L., et al. (1993) · Science · doi:10.1126/science.8493574 · Cited by 2,973
Self-citationMutations of the VHL tumour suppressor gene in renal carcinoma
Gnarra, J. R., Tory, K., Weng, Y., Schmidt, L., Wei, M. H., Li, H., Latif, F., Liu, S., Chen, F., Duh, F.-M., et al. (1994) · Nature Genetics · doi:10.1038/ng0594-85 · Cited by 1,730
Self-citationSilencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.
Herman, J. G., Latif, F., Weng, Y., Lerman, M. I., Zbar, B., Liu, S., Samid, D., Duan, D. S., Gnarra, J. R., & Linehan, W. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9700 · Cited by 1,529
Self-citationCOBRA: a sensitive and quantitative DNA methylation assay
Xiong, Z., & Laird, P. W. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.12.2532 · Cited by 1,195
Dammann, R., Li, C., Yoon, J.-H., Chin, P. L., Bates, S., & Pfeifer, G. P. (2000) · Nature Genetics · doi:10.1038/77083 · Cited by 1,064
Epigenetic Inactivation of RASSF1A in Lung and Breast Cancers and Malignant Phenotype Suppression
Burbee, D. G., Forgacs, E., Zochbauer-Muller, S., Shivakumar, L., Fong, K., Gao, B., Randle, D., Kondo, M., Virmani, A., Bader, S., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.9.691 · Cited by 769
Self-citationLerman, M. I., & Minna, J. D. (2000) · PubMed · Cited by 632
Self-citationAgathanggelou, A., Honorio, S., Macartney, D. P., Martinez, A., Dallol, A., Rader, J., Fullwood, P., Chauhan, A., Walker, R., Shaw, J. A., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204175 · Cited by 376
Self-citationRas Uses the Novel Tumor Suppressor RASSF1 as an Effector to Mediate Apoptosis
Vos, M. D., Ellis, C. A., Bell, A., Birrer, M. J., & Clark, G. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000463200 · Cited by 289
Maher, E. R., Yates, J. R., & Ferguson-Smith, M. A. (1990) · Journal of Medical Genetics · doi:10.1136/jmg.27.5.311 · Cited by 177
A detailed deletion mapping of the short arm of chromosome 3 in sporadic renal cell carcinoma.
Yamakawa, K., Morita, R., Takahashi, E., Hori, T., Ishikawa, J., & Nakamura, Y. (1991) · PubMed · Cited by 142
Involvement of multiple loci on chromosome 3 in renal cell cancer development
van den Berg, A., & Buys, C. H. C. M. (1997) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199706)19:2<59::aid-gcc1>3.0.co;2-z · Cited by 101
Combined LOH/CGH analysis proves the existence of interstitial 3p deletions in renal cell carcinoma
Alimov, A. A., Kost‐Alimova, M., Liu, J., Li, C., Bergerheim, U. S. R., Imreh, S., Klein, G., & Zabarovsky, E. R. (2000) · Oncogene · doi:10.1038/sj.onc.1203449 · Cited by 84
Self-citationFamilial non-VHL non-papillary clear-cell renal cancer
Teh, B. T., Giraud, S., Sari, N. F., Hii, S.-I., Bergerat, J. P., Larsson, C., Limacher, J. M., & Nicol, D. L. (1997) · The Lancet · doi:10.1016/s0140-6736(05)61751-5 · Cited by 54
Woodward, E. R., Clifford, S. C., Astuti, D., Affara, N. A., & Maher, E. R. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.5.348 · Cited by 52
Payne, S. J., Richards, F. M., & Maher, E. R. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.2.390 · Cited by 21
Kuzmin, I., Geil, L., Ge, H., Bengtsson, U., Duh, F.-M. C., Stanbridge, E. J., & Lerman, M. I. (1999) · Oncogene · doi:10.1038/sj.onc.1202959 · Cited by 20
Self-citationLoss of Heterozygosity on the Short Arm of Chromosome 3 in Renal Cancer
Maestro, M. L., del Barco, V., Casla, M. T. S., Moreno, J., Adrover, E., Izquierdo, L. G., Zanna, I., Fernández, C., Redondo, E., Blanco, J., et al. (2000) · Oncology · doi:10.1159/000012149 · Cited by 16
Cited by
Christman, J. K. (2002) · Oncogene · doi:10.1038/sj.onc.1205699 · Cited by 1,525
Ubiquitous Activation of Ras and Jak/Stat Pathways in Human HCC
Calvisi, D. F., Ladu, S., Gorden, A., Farina, M., Conner, E. A., Lee, J., Factor, V. M., & Thorgeirsson, S. S. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.006 · Cited by 710
Donninger, H., Vos, M. D., & Clark, G. J. (2007) · Journal of Cell Science · doi:10.1242/jcs.010389 · Cited by 440
The RASSF1A Tumor Suppressor Blocks Cell Cycle Progression and Inhibits Cyclin D1 Accumulation
Shivakumar, L., Minna, J., Sakamaki, T., Pestell, R., & White, M. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.12.4309-4318.2002 · Cited by 393
Self-citationRole of the Ras-Association Domain Family 1 Tumor Suppressor Gene in Human Cancers
Agathanggelou, A., Cooper, W. N., & Latif, F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4088 · Cited by 388
Metadata
- Authors
- Dreijerink, K., Braga, E., Kuzmin, I., Geil, L., Duh, F.-M., Angeloni, D., Zbar, B., Lerman, M. I., Stanbridge, E. J., Minna, J. D., Protopopov, A., Li, J., Kashuba, V., Klein, G., & Zabarovsky, E. R.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2001-06-05
- Volume
- 98
- Issue
- 13
- Pages
- 7504-7509
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2032053235
- Cited by
- 294
- References
- 18
- FWCI
- 10.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.